PUBLISHER: GlobalData | PRODUCT CODE: 1726104
PUBLISHER: GlobalData | PRODUCT CODE: 1726104
Dental Bone Graft Substitutes & Regenerative Materials Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Dental Devices therapeutic area.
Dental bone grafts and substitutes are used to augment or fill a defect created by surgery, trauma, disease, or developmental deficiency. Bone grafts and regenerative materials regenerate the natural bone and dental tissue.
Bone grafts, tissue regenerative materials, and growth factors are used to replace and regenerate tissue lost due to disease or trauma. Dental materials, including cements, bonding agents, and impression materials, are utilized in various dental interventions. Dental bone grafts come in organic or synthetic forms. Organic bone grafts, such as allografts and xenografts, are sourced from donors, while synthetic bone grafts are made from inorganic materials like calcium sulfate, calcium phosphate, tricalcium phosphate (TCP), or coralline hydroxyapatite. These grafts are available in blocks, gels, pastes, particulates, putty, or strips.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with Intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Dental Bone Graft Substitutes & Regenerative Materials market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Straumann Holding AG, Dentsply Sirona Inc, ZimVie Inc, Dentium Co Ltd, LifeNet Health Inc, Geistlich Pharma AG and Others.
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -